Wibowo P, Fatichah C
    
    
    J King Saud Univ Comput Inf Sci. 2024; 34(9):7830-7839.
  
  
    PMID: 38620726
    
          PMC: 8482553.
    
          DOI: 10.1016/j.jksuci.2021.09.021.
      
 
                                  
  
    Georgas A, Georgas K, Hristoforou E
    
    
    Micromachines (Basel). 2023; 14(8).
  
  
    PMID: 37630054
    
          PMC: 10456522.
    
          DOI: 10.3390/mi14081518.
      
 
                                  
  
    Hogg C, Boots S, Howorth D, Williams C, Heginbothom M, Salmon J
    
    
    PLoS One. 2023; 18(8):e0290406.
  
  
    PMID: 37611000
    
          PMC: 10446167.
    
          DOI: 10.1371/journal.pone.0290406.
      
 
                                  
  
    Yari P, Rezaei B, Dey C, Chugh V, Veerla N, Wang J
    
    
    Sensors (Basel). 2023; 23(9).
  
  
    PMID: 37177614
    
          PMC: 10181768.
    
          DOI: 10.3390/s23094411.
      
 
                                  
  
    Whitfield C, Van Tongeren M, Han Y, Wei H, Daniels S, Regan M
    
    
    PLoS One. 2023; 18(5):e0284805.
  
  
    PMID: 37146037
    
          PMC: 10162531.
    
          DOI: 10.1371/journal.pone.0284805.
      
 
                              
              
                              
                                      
  Modelling the impact of repeat asymptomatic testing policies for staff on SARS-CoV-2 transmission potential.
  
    Whitfield C, Hall I
    
    
    J Theor Biol. 2022; 557:111335.
  
  
    PMID: 36334850
    
          PMC: 9626407.
    
          DOI: 10.1016/j.jtbi.2022.111335.
      
 
                                          
                                                          
  Magnetic nanoparticles and magnetic particle spectroscopy-based bioassays: a 15 year recap.
  
    Wu K, Liu J, Chugh V, Liang S, Saha R, Krishna V
    
    
    Nano Futures. 2022; 6(2).
  
  
    PMID: 36199556
    
          PMC: 9531898.
    
          DOI: 10.1088/2399-1984/ac5cd1.
      
 
                                          
                                                          
  Comparing lateral flow testing with a rapid RT-PCR method for SARS-CoV-2 detection in the United Kingdom-A retrospective diagnostic accuracy study.
  
    Taylor A, Calvez R, Atkins M, Fink C
    
    
    Health Sci Rep. 2022; 5(5):e811.
  
  
    PMID: 36177402
    
          PMC: 9475223.
    
          DOI: 10.1002/hsr2.811.
      
 
                                          
                                                          
  Cost-effectiveness of a whole-area testing pilot of asymptomatic SARS-CoV-2 infections with lateral flow devices: a modelling and economic analysis study.
  
    Drakesmith M, Collins B, Jones A, Nnoaham K, Thomas D
    
    
    BMC Health Serv Res. 2022; 22(1):1190.
  
  
    PMID: 36138455
    
          PMC: 9502892.
    
          DOI: 10.1186/s12913-022-08511-3.
      
 
                                          
                                                          
  Alternative COVID-19 mitigation measures in school classrooms: analysis using an agent-based model of SARS-CoV-2 transmission.
  
    Woodhouse M, Aspinall W, Sparks R, Brooks-Pollock E, Relton C
    
    
    R Soc Open Sci. 2022; 9(8):211985.
  
  
    PMID: 35958084
    
          PMC: 9363991.
    
          DOI: 10.1098/rsos.211985.
      
 
                                          
                                                          
  COVID-19 Testing Strategies for K-12 Schools in California: A Cost-Effectiveness Analysis.
  
    Maya S, McCorvie R, Jacobson K, Shete P, Bardach N, Kahn J
    
    
    Int J Environ Res Public Health. 2022; 19(15).
  
  
    PMID: 35954728
    
          PMC: 9367893.
    
          DOI: 10.3390/ijerph19159371.
      
 
                                          
                                                          
  COVID-19: Clinical laboratory diagnosis and monitoring of novel coronavirus infected patients using molecular, serological and biochemical markers: A review.
  
    Rasool G, Riaz M, Abbas M, Fatima H, Qamar M, Zafar F
    
    
    Int J Immunopathol Pharmacol. 2022; 36:3946320221115316.
  
  
    PMID: 35840546
    
          PMC: 9289644.
    
          DOI: 10.1177/03946320221115316.
      
 
                                          
                                                          
  An all-in-one point-of-care testing device for multiplexed detection of respiratory infections.
  
    Teixeira W, Pallas-Tamarit Y, Juste-Dolz A, Sena-Torralba A, Gozalbo-Rovira R, Rodriguez-Diaz J
    
    
    Biosens Bioelectron. 2022; 213:114454.
  
  
    PMID: 35696866
    
          PMC: 9176175.
    
          DOI: 10.1016/j.bios.2022.114454.
      
 
                                          
                                                          
  Microfluidic particle dam for direct visualization of SARS-CoV-2 antibody levels in COVID-19 vaccinees.
  
    Wu M, Wu S, Wang G, Liu W, Chu L, Jiang T
    
    
    Sci Adv. 2022; 8(22):eabn6064.
  
  
    PMID: 35658040
    
          PMC: 9166397.
    
          DOI: 10.1126/sciadv.abn6064.
      
 
                                          
                                                          
  Exploration of the uptake of asymptomatic COVID-19 lateral flow testing in Birmingham, UK: survey and qualitative research.
  
    Mathers J, Poyner C, Thompson D, Rudge G, Pritchett R
    
    
    BMJ Open. 2022; 12(4):e056606.
  
  
    PMID: 35443954
    
          PMC: 9021457.
    
          DOI: 10.1136/bmjopen-2021-056606.
      
 
                                          
                                                          
  Who is accessing community lateral flow device testing and why? Characteristics and motivations of individuals participating in COVID-19 community testing in two English local authority areas.
  
    Dalili M, Long J, Wadley E, Sloan J, Cross A, Thomas K
    
    
    BMC Public Health. 2022; 22(1):588.
  
  
    PMID: 35337297
    
          PMC: 8956328.
    
          DOI: 10.1186/s12889-022-12986-4.
      
 
                                          
                                                          
  SARS-CoV-2 antigen lateral flow tests for detecting infectious people: linked data analysis.
  
    Deeks J, Singanayagam A, Houston H, Sitch A, Hakki S, Dunning J
    
    
    BMJ. 2022; 376:e066871.
  
  
    PMID: 35197270
    
          PMC: 8864475.
    
          DOI: 10.1136/bmj-2021-066871.
      
 
                                          
                                                          
  Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk.
  
    Smith D, Duval A, Zahar J, Opatowski L, Temime L
    
    
    Nat Commun. 2022; 13(1):236.
  
  
    PMID: 35017499
    
          PMC: 8752617.
    
          DOI: 10.1038/s41467-021-27845-w.
      
 
                                          
                                                          
  Behind the curtain of a weak diagnosis of acute SARS-CoV-2 infection in children.
  
    Caballero M
    
    
    J Pediatr (Rio J). 2021; 98(2):113-114.
  
  
    PMID: 34953777
    
          PMC: 8685182.
    
          DOI: 10.1016/j.jped.2021.12.003.
      
 
                                          
                                                          
  Point-of-Care Testing-The Key in the Battle against SARS-CoV-2 Pandemic.
  
    Iliescu F, Ionescu A, Gogianu L, Simion M, Dediu V, Chifiriuc M
    
    
    Micromachines (Basel). 2021; 12(12).
  
  
    PMID: 34945314
    
          PMC: 8708595.
    
          DOI: 10.3390/mi12121464.